637 related articles for article (PubMed ID: 26820415)
21. Advances in biotechnology: new tools in future pig production for agriculture and biomedicine.
Niemann H; Rath D; Wrenzycki C
Reprod Domest Anim; 2003 Apr; 38(2):82-9. PubMed ID: 12654017
[TBL] [Abstract][Full Text] [Related]
22. Will Genetic Engineering Carry Xenotransplantation of Pig Islets to the Clinic?
Kemter E; Denner J; Wolf E
Curr Diab Rep; 2018 Sep; 18(11):103. PubMed ID: 30229378
[TBL] [Abstract][Full Text] [Related]
23. Transgenic expression of human heme oxygenase-1 in pigs confers resistance against xenograft rejection during ex vivo perfusion of porcine kidneys.
Petersen B; Ramackers W; Lucas-Hahn A; Lemme E; Hassel P; Queisser AL; Herrmann D; Barg-Kues B; Carnwath JW; Klose J; Tiede A; Friedrich L; Baars W; Schwinzer R; Winkler M; Niemann H
Xenotransplantation; 2011; 18(6):355-68. PubMed ID: 22168142
[TBL] [Abstract][Full Text] [Related]
24. The emergence of xenotransplantation.
Fryer JP; Leventhal JR; Matas AJ
Transpl Immunol; 1995 Mar; 3(1):21-31. PubMed ID: 7551975
[TBL] [Abstract][Full Text] [Related]
25. [Transgenic pigs for xenotransplantation for humans].
Niemann H
Dtsch Tierarztl Wochenschr; 1999 Apr; 106(4):141-6. PubMed ID: 10354642
[TBL] [Abstract][Full Text] [Related]
26. Pigs transgenic for human thrombomodulin have elevated production of activated protein C.
Petersen B; Ramackers W; Tiede A; Lucas-Hahn A; Herrmann D; Barg-Kues B; Schuettler W; Friedrich L; Schwinzer R; Winkler M; Niemann H
Xenotransplantation; 2009; 16(6):486-95. PubMed ID: 20042048
[TBL] [Abstract][Full Text] [Related]
27. Xenotransplantation literature update, November/December 2019.
Thomas A; Hawthorne WJ; Burlak C
Xenotransplantation; 2020 Jan; 27(1):e12582. PubMed ID: 31984549
[TBL] [Abstract][Full Text] [Related]
28. The study of mitoxantrone as a potential immunosuppressor in transgenic pig renal xenotransplantation in baboons: comparison with cyclophosphamide.
Ashton-Chess J; Meurette G; Karam G; Petzold T; Minault D; Naulet J; Tesson L; Plat M; Anegon I; Soulillou JP; Blancho G
Xenotransplantation; 2004 Mar; 11(2):112-22. PubMed ID: 14962273
[TBL] [Abstract][Full Text] [Related]
29. Mechanism of delayed rejection in transgenic pig-to-primate cardiac xenotransplantation.
Chen RH; Kadner A; Mitchell RN; Adams DH
J Surg Res; 2000 May; 90(2):119-25. PubMed ID: 10792951
[TBL] [Abstract][Full Text] [Related]
30. Production of genetically modified pigs expressing human insulin and C-peptide as a source of islets for xenotransplantation.
Cho B; Lee EJ; Ahn SM; Kim G; Lee SH; Ji DY; Kang JT
Transgenic Res; 2019 Dec; 28(5-6):549-559. PubMed ID: 31473874
[TBL] [Abstract][Full Text] [Related]
31. [Transgenic pigs for xenotransplants for humans].
Niemann H
Zentralbl Chir; 1998; 123(7):781-4. PubMed ID: 9746975
[TBL] [Abstract][Full Text] [Related]
32. Silencing porcine genes significantly reduces human-anti-pig cytotoxicity profiles: an alternative to direct complement regulation.
Butler JR; Martens GR; Estrada JL; Reyes LM; Ladowski JM; Galli C; Perota A; Cunningham CM; Tector M; Joseph Tector A
Transgenic Res; 2016 Oct; 25(5):751-9. PubMed ID: 27100221
[TBL] [Abstract][Full Text] [Related]
33. Production of α1,3-galactosyltransferase and cytidine monophosphate-N-acetylneuraminic acid hydroxylase gene double-deficient pigs by CRISPR/Cas9 and handmade cloning.
Gao H; Zhao C; Xiang X; Li Y; Zhao Y; Li Z; Pan D; Dai Y; Hara H; Cooper DK; Cai Z; Mou L
J Reprod Dev; 2017 Feb; 63(1):17-26. PubMed ID: 27725344
[TBL] [Abstract][Full Text] [Related]
34. Progress in xenotransplantation following the introduction of gene-knockout technology.
Tai HC; Ezzelarab M; Hara H; Ayares D; Cooper DK
Transpl Int; 2007 Feb; 20(2):107-17. PubMed ID: 17239018
[TBL] [Abstract][Full Text] [Related]
35. Alpha1,3-galactosyltransferase gene-knockout pigs for xenotransplantation: where do we go from here?
Cooper DK; Dorling A; Pierson RN; Rees M; Seebach J; Yazer M; Ohdan H; Awwad M; Ayares D
Transplantation; 2007 Jul; 84(1):1-7. PubMed ID: 17627227
[TBL] [Abstract][Full Text] [Related]
36. The immense potential of xenotransplantation in surgery.
Cooper DK; Ayares D
Int J Surg; 2011; 9(2):122-9. PubMed ID: 21059418
[TBL] [Abstract][Full Text] [Related]
37. Progress in xenotransplantation.
Cozzi E; Masroor S; Soin B; Vial C; White DJ
Clin Nephrol; 2000 Apr; 53(4):suppl 13-8. PubMed ID: 10809429
[TBL] [Abstract][Full Text] [Related]
38. Potential use of genetically modified pigs as organ donors for transplantation into humans.
Logan JS; Sharma A
Clin Exp Pharmacol Physiol; 1999 Dec; 26(12):1020-5. PubMed ID: 10626075
[TBL] [Abstract][Full Text] [Related]
39. The International Xenotransplantation Association consensus statement on conditions for undertaking clinical trials of porcine islet products in type 1 diabetes--chapter 5: Strategies to prevent transmission of porcine endogenous retroviruses.
Denner J; Schuurman HJ; Patience C
Xenotransplantation; 2009; 16(4):239-48. PubMed ID: 19799764
[TBL] [Abstract][Full Text] [Related]
40. The fate of human platelets exposed to porcine renal endothelium: a single-pass model of platelet uptake in domestic and genetically modified porcine organs.
Butler JR; Martens GR; Li P; Wang ZY; Estrada JL; Ladowski JM; Tector M; Tector AJ
J Surg Res; 2016 Feb; 200(2):698-706. PubMed ID: 26375504
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
